Harmony Biosciences: Q2 Earnings Insights

Harmony Biosciences HRMY reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Harmony Biosciences beat estimated earnings by 29.55%, reporting an EPS of $0.57 versus an estimate of $0.44.

Revenue was up $33.21 million from the same period last year.

Last quarter the company beat on EPS by $0.22 which was followed by a 3.01% increase in the share price the next day.

Here's a look at Harmony Biosciences's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.29	0.37	0.28	0.18
EPS Actual	0.51	0.63	0.51	0.54
Revenue Estimate	88.55M	90.01M	79.85M	68.77M
Revenue Actual	85.31M	91.21M	80.73M	73.82M

To track all earnings releases for Harmony Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar